Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall this week
March 23, 2022Sobi to trim staff as Pfizer manufacturing contract ends early
March 24, 2022Novartis’ radiotherapy Pluvicto nabs FDA approval for prostate cancer, with $2B-plus peak sales expectations
aliu
Thu, 03/24/2022 – 05:42
